摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl [(3R,4R)-1-(3-methylpyrido[2,3-b]pyrazin-6-yl)-4-(2,4,5-trifluorophenyl)piperidin-3-yl]carbamate

中文名称
——
中文别名
——
英文名称
tert-butyl [(3R,4R)-1-(3-methylpyrido[2,3-b]pyrazin-6-yl)-4-(2,4,5-trifluorophenyl)piperidin-3-yl]carbamate
英文别名
tert-Butyl [(3R,4R)-1-(3-methylpyrido[2,3-b]pyrazin-6-yl)-4-(2,4,5-trifluorophenyl)piperidin-3-yl]carbamate;tert-butyl N-[(3R,4R)-1-(3-methylpyrido[2,3-b]pyrazin-6-yl)-4-(2,4,5-trifluorophenyl)piperidin-3-yl]carbamate
tert-butyl [(3R,4R)-1-(3-methylpyrido[2,3-b]pyrazin-6-yl)-4-(2,4,5-trifluorophenyl)piperidin-3-yl]carbamate化学式
CAS
——
化学式
C24H26F3N5O2
mdl
——
分子量
473.498
InChiKey
OJLKESBXFCOGLA-VLIAUNLRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    34
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    80.2
  • 氢给体数:
    1
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
    申请人:Cox M. Jason
    公开号:US20080076773A1
    公开(公告)日:2008-03-27
    The present invention is directed to novel substituted aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
    本发明涉及一种新型的取代氨基哌啶,它是二肽基肽酶-IV酶(“DPP-IV酶”)的抑制剂,并且在治疗或预防DPP-IV酶参与的疾病,如糖尿病,尤其是2型糖尿病方面具有用处。本发明还涉及包含这些化合物的制药组合物,以及使用这些化合物和组合物在预防或治疗DPP-IV酶参与的这些疾病方面的用途。
  • Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
    申请人:Merck Sharp & Dohme Corp.
    公开号:US07884104B2
    公开(公告)日:2011-02-08
    The present invention is directed to novel substituted aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
    本发明涉及新型取代氨基哌啶类化合物,它们是二肽基肽酶-IV酶(“DPP-IV抑制剂”)的抑制剂,可用于治疗或预防涉及二肽基肽酶-IV酶的疾病,如糖尿病,尤其是2型糖尿病。本发明还涉及包含这些化合物的制药组合物以及在涉及二肽基肽酶-IV酶的这种疾病的预防或治疗中使用这些化合物和组合物。
  • [EN] AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES<br/>[FR] AMINOPIPERIDINES UTILISEES COMME INHIBITEURS DE LA DIPEPTIDYLE PEPTIDASE-IV POUR LE TRAITEMENT OU LA PREVENTION DU DIABETE
    申请人:MERCK & CO INC
    公开号:WO2006039325A3
    公开(公告)日:2007-01-04
查看更多